Clinical Trial Update: Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs

View source ↗

Summary

A completed Asian trial evaluating Lanreotide Autogel for Gastroenteropancreatic neuroendocrine tumors. The snippet notes completion but does not include effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumors

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Asan Medical Center | Conditions: Neuroendocrine Tumors | Status: COMPLETED